Others

Glenmark Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

| Updated on February 20, 2019 Published on February 20, 2019

Glenmark Pharmaceuticals to Present New Analysis of Pooled Data on Ryaltris™, an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual MeetingGlenmark Pharmaceuticals to Present New Analysis of Pooled Data on Ryaltris™, an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual Meeting

Pdf Link: Glenmark Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on February 20, 2019
This article is closed for comments.
Please Email the Editor